All projects
opendiligenceCell therapyCell therapy

Diligence advisor — CMC manufacturing risk

Sponsor undisclosed (revealed after NDA)· posted 1 day ago

About this engagement

Sponsor undisclosed (PE/VC). Single 20-hour engagement to review CMC manufacturing risk on a prospective Series B target. NDA required.

Required capabilities

Cell therapy CMCManufacturing diligence

Nice to have

Recent PE/VC diligence experience
About the sponsor

Sponsor identity is hidden until you sign an NDA. They've completed 6 LynQX engagements in the past 18 months and have a 100% on-time payment record.